Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M…
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M…
All over the world, the life sciences industry is booming. Biotechnology, in particular, is experiencing…
Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs…
Novacyt will use the money raised on the AIM market, London, to expand its manufacturing…
Fresh from announcing positive Phase III results, Ablynx has wasted no time in filing a…
Nucana Biomed has filed for a Nasdaq IPO in which it expects to raise up…
Destiny Pharma has started trading on the London Stock Exchange to support its search for…
After announcing its intentions last month, Zealand Pharma has gone public in the US to…
Zealand Pharma, known for its partnership with Sanofi to boost the insulin blockbuster Lantus, is…
In our first Refresh expert track presentation the audience had the chance to learn about…
UPDATE (22/05/2017): Argenx has gone above and beyond to secure $115M (€103M) on the NASDAQ. Underwriters…
After its record €277 IPO on Nasdaq in 2015, Galapagos announced the pricing of its new…